Even though section 1201 of the Patient Protection and Affordable Care Act — the section that enables health payers to charge a 50% premium on smokers — won't go into effect until 2015, smoking cessation will be a growing category in 2014.
There hasn't been a lot of growth in intimacy health lately, with the exception of intimacy enhancement devices, which are up 16.5% to a relatively small $26.2 million base for the 52 weeks ended June 16, according to IRI. But there is plenty of opportunity to drive growth into the category moving forward, especially with the Millennials entering the marketplace.
With the launch of Procter & Gamble's ZzzQuil, a relatively quiet sleep category has exploded with energy this year. A lot of that has to do with the $121.1 million in sales that ZzzQuil — both tablet and liquid formulations — has generated this year.
Martha Stewart, who is launching her own line of supplements at NACDS Total Store Expo, couched the aging of America as a "silver tsunami" that will have older Americans streaming toward all things health and wellness.
The coming cough-cold season is difficult to project. On one hand, this year's cough-cold incidence will be going against very strong illness rate numbers from last year. In addition, with both McNeil Consumer and Novartis Consumer supporting the relaunch of a number of cough-cold products, the category is expected to be very promotional this season, a factor that could squeeze margins.
One of the biggest problems with the healthcare reform law is that a lot of people out there don't fully understand it. To educate the general public about the law, a few organizations have come up with simple, online tools aimed at dispelling the confusion.
Results of a recent federal survey of Medicare Part D claims is again roiling the sometimes strained relationship between independent and smaller-chain community pharmacies and managed care, and could herald a growing threat to those pharmacies as health plan payers and pharmacy benefit managers abandon open pharmacy provider networks and shift more business to exclusive preferred pharmacy groups.